Peripheral Neuropathy Trial, Recruiting (NCT07274735)

Peripheral Neuropathy Trial, Recruiting NCT07274735 Sponsor: Riphah International University Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT07274735 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 50 and 75 years old
You are male or female
You have been diagnosed with type 2 diabetes by a doctor
You have scored 4 or higher on a questionnaire called the DN4, which is used to assess nerve pain (confirm with trial site)
You are able to complete a simple "stand up and walk" test in less than 15 seconds (confirm with trial site)
You are able to walk at least 10 meters (roughly 33 feet) on your own

Who may not be able to join:

You have other serious health conditions besides diabetes, such as kidney failure, poorly controlled high blood pressure, severe cholesterol problems, chronic liver disease, autoimmune conditions, or advanced lung disease
You currently have a documented problem with alcohol or drug misuse
You have had part or all of one or both legs amputated
You are severely obese or currently pregnant (based on self-reporting)
You have an active inflammation or a nerve condition that is not related to diabetes, such as nerve damage from chemotherapy, certain immune-related nerve diseases, nerve damage caused by vitamin B12 deficiency, or other nerve conditions not linked to diabetes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aruba Saeed, PhD, Riphah International University

Phone: 03324390125

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07274735

Sponsor: Riphah International University

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: 03324390125

More information: https://clinicaltrials.gov/study/NCT07274735

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 50 and 75 years old
You are male or female
You have been diagnosed with type 2 diabetes by a doctor
You have scored 4 or higher on a questionnaire called the DN4, which is used to assess nerve pain (confirm with trial site)
You are able to complete a simple "stand up and walk" test in less than 15 seconds (confirm with trial site)
You are able to walk at least 10 meters (roughly 33 feet) on your own

Who may not be able to join:

You have other serious health conditions besides diabetes, such as kidney failure, poorly controlled high blood pressure, severe cholesterol problems, chronic liver disease, autoimmune conditions, or advanced lung disease
You currently have a documented problem with alcohol or drug misuse
You have had part or all of one or both legs amputated
You are severely obese or currently pregnant (based on self-reporting)
You have an active inflammation or a nerve condition that is not related to diabetes, such as nerve damage from chemotherapy, certain immune-related nerve diseases, nerve damage caused by vitamin B12 deficiency, or other nerve conditions not linked to diabetes

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Riphah International University

Registry

ClinicalTrials.gov

Start date

17 October 2024

Est. completion

17 January 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

DN4; Mini BESTest scale; Quality of Life- Diabetic Neuropathy Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov